We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.59B
AUM Growth
+$1.23B
Cap. Flow
-$770M
Cap. Flow %
-13.79%
Top 10 Hldgs %
47.55%
Holding
148
New
37
Increased
36
Reduced
28
Closed
32

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$87.6M
2
BURL icon
Burlington
BURL
+$81.6M
3
TVTX icon
Travere Therapeutics
TVTX
+$66.9M
4
HAE icon
Haemonetics
HAE
+$44.2M
5
WSM icon
Williams-Sonoma
WSM
+$43.8M

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$74.6M
2
LNTH icon
Lantheus
LNTH
+$57.7M
3
AAP icon
Advance Auto Parts
AAP
+$50.2M
4
NKE icon
Nike
NKE
+$42.9M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$40.6M

Sector Composition

Rank Sector Weight
1 Healthcare 43.79%
2 Consumer Discretionary 10.03%
3 Consumer Staples 7.94%
4 Communication Services 2.1%
5 Industrials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAF
101
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$2.96M 0.05%
+8,605
New +$3.3M
INM icon
102
InMed Pharmaceuticals
INM
$7.85M
$2.83M 0.05%
1,780
+1,310
+279% +$2.03M
NERV icon
103
Minerva Neurosciences
NERV
$185M
$2.12M 0.04%
114,000
– –
DBGIW
104
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
$1.23M 0.02%
+7,229
New +$535K
GMVDW
105
DELISTED
G Medical Innovations Holdings Ltd. Warrants
GMVDW
$1.03M 0.02%
+1,000,000
New +$938K
SBEV.WS
106
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$963K 0.02%
+875,000
New +$772K
LEXXW
107
DELISTED
Lexaria Bioscience Warrant
LEXXW
$908K 0.02%
361,905
– –
GROMW
108
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$723K 0.01%
+24,100
New +$583K
MDGSW
109
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$720K 0.01%
1,285,715
– –
SYTAW
110
DELISTED
Siyata Mobile Warrant
SYTAW
$696K 0.01%
150,000
– –
BCTXW
111
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$675K 0.01%
375,000
-45,536
-11% -$56.8K
XELA
112
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$478K 0.01%
50
-405
-89% -$2.81M
GROY.WS
113
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$470K 0.01%
448,000
– –
NLSPW
114
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$452K 0.01%
500,000
– –
GRDX
115
GridAI Technologies Corp
GRDX
$20.4M
– –
0
– –
DTSTW
116
DELISTED
Data Storage Corp Warrant
DTSTW
$18K ﹤0.01%
+15,000
New +$14.3K
AAP icon
117
Advance Auto Parts
AAP
$3.35B
– –
-273,469
Closed -$50.2M
ADBE icon
118
Adobe
ADBE
$99.5B
– –
-54,000
Closed -$25.7M
AEO icon
119
American Eagle Outfitters
AEO
$2.88B
– –
-387,995
Closed -$11.3M
ALT icon
120
Altimmune
ALT
$552M
– –
-536,000
Closed -$7.57M
AUUDW
121
DELISTED
Auddia Inc Warrants
AUUDW
– –
-30,400
Closed -$21K
AVTR icon
122
Avantor
AVTR
$9.32B
– –
-636,000
Closed -$18.4M
BGS icon
123
B&G Foods
BGS
$287M
– –
-288,000
Closed -$8.95M
DT icon
124
Dynatrace
DT
$12.9B
– –
-150,000
Closed -$7.24M
FIVE icon
125
Five Below
FIVE
$12B
– –
-66,800
Closed -$12.7M
2 3 4
5
6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Armistice Capital held 148 positions worth $5.59B, up 28% from $4.36B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Armistice Capital withdrew a net $770M in Q2 2021, closing 32 positions and reducing 28 holdings. Its most notable exit was TJX Companies, an estimated $74.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Iovance Biotherapeutics worth $87.7M.

  • Armistice Capital's largest Q2 2021 buy was Iovance Biotherapeutics: 3,372,000 shares worth $87.7M.
  • Armistice Capital added most to Travere Therapeutics in Q2 2021, an estimated $66.9M increase.
  • Armistice Capital's biggest Q2 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $40.6M.
  • Armistice Capital fully exited TJX Companies in Q2 2021, selling an estimated $74.6M.
  • Armistice Capital's ten largest holdings make up 48% of its $5.59B portfolio in Q2 2021.
  • Armistice Capital opened 37 new positions and closed 32 in Q2 2021.
  • Armistice Capital's portfolio value rose 28% quarter-over-quarter to $5.59B.

Based on Armistice Capital's 13F filing for Q2 2021, filed 16 Aug 2021.